In precision oncology, tissue quality plays a pivotal role in maintaining data integrity. We explore the impact of standardizing tissue collection and processing on data quality, and how this helps enhance patient outcomes as well as our understanding of cancer. Insights from tissue samples play an important role across the drug life cycle – from […]
The life sciences ecosystem is facing a critical moment of transformation, driven by a new generation of startups that adopt a novel approach to scaling up. Unwilling to conform to the status quo, these life sciences startups are challenging conventional methods by adopting a tiger team approach—a dynamic and agile strategy to tackle the intricate […]
In the rapidly evolving healthcare landscape, cell and gene therapies (CGTs) have emerged as revolutionary treatments offering hope to patients with previously incurable diseases. However, the success of CGTs hinges on maintaining integrity through the supply chain, a task made daunting by the extreme temperature sensitivity of these therapies. We delve into the critical role […]
In most cases, chronic inflammation is known to lead to cancer, however, the mechanisms behind this are not fully understood. Preclinical models in immuno-oncology are the first step towards a better understanding of cancer mechanisms, improved treatments and prevention of cancer caused by inflammation. Inflammation is the immune system’s natural response to bacterial, viral, and […]
Thanks to their unique features, bispecific antibodies are the fastest-evolving class of biotherapeutics. However, the enormous clinical potential of their unconventional design is accompanied by equally large challenges. How can we ensure reliable production and quality control of therapeutic bispecific antibodies? Compared to monoclonal antibodies, bispecific antibodies (bsAbs) have two different binding areas that recognize […]